Holding(s) in Company

Allergy Therapeutics PLC
28 March 2006



Allergy Therapeutics plc ("the Company")


The Company received notification on 27 March 2006 that Fidelity International
Limited ("FIL") and its direct and indirect subsidiaries, including Fidelity
Investment Services Ltd ("FISL"), Fidelity Gestion (FIGEST), Fidelity
Investments Advisory (Korea) Limited (FIA(K)L), Fidelity Investments Management
(Hong Kong) Limited (FIMHK), Fidelity Pension Management ("FPM") and Fidelity
Investments International (FII), investment managers for various non-US
investment companies and institutional clients, are together interested in a
total of 9,442,594 ordinary shares in the Company, representing approximately
14.99 per cent. of the Company's issued share capital.


This shareholding is registered as follows:


  Shares held      Management Company                    Nominee/Registered Name
    1,478,900             FPM                              Northern Trust London
      663,500             FPM                                        Mellon Bank
      611,100             FPM                             JP Morgan, Bournemouth
      484,600             FPM                           Bank of New York Brussels
      457,784             FPM                        State Str Bk and Tr Co Lndn
      317,700             FPM                               Bankers Trust London
      150,100             FPM                        Midland Securities Services
       80,200             FPM                                Clydesdale Bank plc
    3,812,798             FISL                            JP Morgan, Bournemouth
      646,000             FIL                         Brown Bros Harrimn Ltd Lux
      155,400             FIL                          Bank of New York Brussels
      584,512             FIL                             JP Morgan, Bournemouth
    9,442,594                                                      Total holding



This notifiable interest also comprises the notifiable interest of Mr Edward C.
Johnson III, a principal shareholder of Fidelity International Limited, and
interests held on behalf of authorised unit trust schemes in the United Kingdom.





                      This information is provided by RNS
            The company news service from the London Stock Exchange